The role of 5-HT(1A) autoreceptors and α1-adrenoceptors in the modulation of 5-HT release - III. Clozapine and the novel putative antipsychotic S 16924

Neuropharmacology

Volumn 37, Issue 3, 1998, Pages 349-356

  Jorgen Bengtsson H ^a   Kullberg, Anders ^a   Millan, Mark J ^b   Hjorth, Stephan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

1 adrenoceptor; 'Atypical' antipsychotic; 5 HT release; 5 HT(1A) autoreceptor; Clozapine; Microdialysis; S 16924 (1 benozodioxane 5 yl) 3 3 4 fluorophenacyl)pyrrolidine 1 oxapropane HCl

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA [1 [2 (1,4 BENZODIOXAN 5 YLOXY)ETHYL] 3 PYRROLIDINYL] 4 FLUOROACETOPHENONE; CIRAZOLINE; CLOZAPINE; HALOPERIDOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AUTORECEPTOR; IMIDAZOLE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRROLIDINE DERIVATIVE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FOREBRAIN; HIPPOCAMPUS; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; SEROTONIN RELEASE; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORECEPTORS; CLOZAPINE; HIPPOCAMPUS; IMIDAZOLES; MALE; MICRODIALYSIS; PIPERAZINES; PYRIDINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0031602698     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00017-3     Document Type: Article

References (31)

1. 2 receptors by novel antipsychotics. Eur. Neuropsychopharmacol. 5, 330 (abstr. # P-4-12).
2. Baldessarini R.J., Huston-Lyons D., Campbell A., Marsh E., Cohen B.M. Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br. J. Psychiat. 160(suppl. 17):1992;12-16.
3. Baraban J.M., Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology. 19:1980;355-363.
4. Baraban J.M., Aghajanian G.K. Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography. Brain Res. 204:1981;1-11.
5. 1A receptors are not involved in clozapine's lack of cataleptogenic potential. Neuropharmacology. 35:1996;1645-1646.
6. Broekkamp C.L.E., Oosterloo S.K., Berendsen H.H.G., van Delft A.M.L. Effect of metergoline, fenfluramine, and 8-OH-DPAT on catalepsy induced by haloperidol or morphine. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;191-195.
7. Brunello N., Masotto C., Steardo L., Markstein R., Racagni G. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology. 13:1995;177-213.
8. 1 receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. J. Pharmacol. Exp. Ther. 246:1988;359-370.
9. Coward D.M. General pharmacology of clozapine. Br. J. Psychiat. 160(suppl. 17):1992;5-11.
10. Ferré S., Artigas F. Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism. Neurosci. Lett. 187:1995;61-64.
11. 1A receptor antagonist. Behav. Brain Res. 73:1995;337-353.
12. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281:1995;81-88.
13. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo - a microdialysis study. J. Neurochem. 60:1993;776-779.
14. 1-adrenoceptors in the inhibition of 5-HT release-I. BMY7378 and prazosin. Neuropharmacology. 34:1995;615-620.
15. 1A autoreceptor mediation of the 5-HT release-reducing action of clozapine and S16924 in rat ventral hippocampus. Soc. Neurosci. Abstr. 23(# 484.5):1997;1222.
16. 1A agonist 8-OH-DPAT preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;463-471.
17. Hoffman D.C., Donovan H. Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology-Berl. 120:1995;128-133.
18. 1-adrenoceptor subtypes. Br. J. Pharmacol. 116:1995;1611-1618.
19. 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe medianus and dorsalis. Neuropharmacology. 27:1988;515-518.
20. 1A receptors. Eur. J. Pharmacol. 260:1994;79-83.
21. 2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Psychopharmacology. 131:1997;57-63.
22. 2 receptors, and an 'atypical' antipsychotic profile in the rat. Br. J. Pharmacol. 114:1995;156P.
23. Neal-Beliveau B.S., Joyce J.N., Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. J. Pharmacol. Exp. Ther. 265:1993;207-217.
24. 1A receptors. Neuropharmacology. 35:1996;119-121.
25. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed:1986;Academic Press, San Diego.
26. Rivet J.-M., Gobert A., Cistarelli L., Girardon S., Muller O., Lavielle G., Millan M.J. The novel atypical antipsychotic S 16924, enhances dopamine (DA) and noradrenaline (NAD) release, and decreases serotonin (5-HT) release, in frontal cortex of freely-moving rats. Soc. Neurosci. Abstr. 22(# 467.1):1996;1187.
27. Sharp T., Hjorth S. In vivo neurochemical studies of 5-HT1A autoreceptor function. Bradley P.B., Handley S.L., Cooper S.J., Key B.J., Barnes N.M., Coote J.H. 5-Hydroxytryptamine, CNS Receptors and Brain Function. 1992;297-323 Pergamon Press, New York, NY.
28. 1-adrenoceptors in the inhibition of 5-HT release-II. NAN-190 and SDZ 216-525. Neuropharmacology. 35:1996;735-741.
29. 1B agonists. Synapse. 1:1987;3-9.
30. Wadenberg M.L., Ahlenius S. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat-enhancement of antipsychotic-like effects without catalepsy. J. Neural Transm. Gen. Sect. 83:1991;43-53.
31. 1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat. Neuropharmacology. 34:1995;495-499.